BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?

Hélène Haguet; Jonathan Douxfils; Christian Chatelain; Carlos Graux; François Mullier; Jean-Michel Dogne

doi:10.1055/s-0038-1624566

BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?

Hélène Haguet, Jonathan Douxfils, Christian Chatelain, Carlos Graux, François Mullier, Jean-Michel Dogne

Résultats de recherche: Contribution à un journal/une revue › Article de revue › Revue par des pairs

2 Téléchargements (Pure)

langue originale	Anglais
Pages (de - à)	e68-e88
journal	TH Open
Volume	02
Numéro de publication	1
Les DOIs	https://doi.org/10.1055/s-0038-1624566
Etat de la publication	Publié - 2018

Accès au document

10.1055/s-0038-1624566

THO_170017

1 Actif

The TiTKI Project - evaluation of the risk of thrombosis associated with the use of tyrosine kinase inhibitors
Douxfils, J., MULLIER, F. & Haguet, H.
1/09/15 → …
Projet: Recherche

Contient cette citation

@article{66a27f13c8b24ae3ad3cff556782919b,

title = "BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?",

keywords = "BCR-ABL, arterial thrombotic events, tyrosine kinase inhibators, chronic myeloid leukemia",

author = "H{\'e}l{\`e}ne Haguet and Jonathan Douxfils and Christian Chatelain and Carlos Graux and Fran{\c c}ois Mullier and Jean-Michel Dogne",

year = "2018",

doi = "10.1055/s-0038-1624566",

language = "English",

volume = "02",

pages = "e68--e88",

journal = "TH Open",

issn = "2512-9465",

publisher = "Thieme Medical Publishers",

number = "1",

}

TY - JOUR

T1 - BCR-ABL Tyrosine Kinase Inhibitors

T2 - Which Mechanism(s) May Explain the Risk of Thrombosis?

AU - Haguet, Hélène

AU - Douxfils, Jonathan

AU - Chatelain, Christian

AU - Graux, Carlos

AU - Mullier, François

AU - Dogne, Jean-Michel

PY - 2018

Y1 - 2018

KW - BCR-ABL

KW - arterial thrombotic events

KW - tyrosine kinase inhibators

KW - chronic myeloid leukemia

U2 - 10.1055/s-0038-1624566

DO - 10.1055/s-0038-1624566

M3 - Review article

VL - 02

SP - e68-e88

JO - TH Open

JF - TH Open

SN - 2512-9465

IS - 1

ER -

BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?

Accès au document

The TiTKI Project - evaluation of the risk of thrombosis associated with the use of tyrosine kinase inhibitors

Contient cette citation